TCMBANKIN000037 |
Pristimerin |
Spectrum4_001681; KBio1_001689; Spectrum5_000322; Spectrum_001558; KBioSS_002038; C08633; KBio2_007174; ACon0_000836; Celastrol-methylether; Spectrum2_000546; DivK1c_006745; pristimerin; 1258-84-0; SDCCGMLS-0066814.P001; MEGxp0_000269; SPBio_000591; KBio2_004606; SpecPlus_000649; KBio3_002621; D:A-Friedo-24-noroleana-1(10),3,5,7-tetraen-29-oic acid, 3-hydroxy-2-oxo-, methyl ester, (20alpha)- (9CI); KBioGR_001942; BSPBio_003401; (2R,4aS,6aS,6aR,14aS,14bR)-10-hydroxy-2,4a,6a,6a,9,14a-hexamethyl-11-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylic acid methyl ester; SPECTRUM1504181; KBio2_002038; (2R,4aS,6aS,6aR,14aS,14bR)-10-hydroxy-11-keto-2,4a,6a,6a,9,14a-hexamethyl-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylic acid methyl ester; methyl (2R,4aS,6aS,6aR,14aS,14bR)-10-hydroxy-2,4a,6a,6a,9,14a-hexamethyl-11-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylate; Spectrum3_001651 |
C30H40O4 |
464.64 |
CC1=C(C(=O)C=C2C1=CC=C3C2(CCC4(C3(CCC5(C4CC(CC5)(C)C(=O)OC)C)C)C)C)O |